← The COO Files

Issue 06 Healthcare · Aesthetic Clinics

She Was an Excellent Doctor. The Business Was a Different Problem.

6 min read

Issue 6 — Healthcare

Then she woke up one morning and realised she had stopped being a doctor.

That was the sentence that stopped me during our first conversation. Not the revenue numbers. Not the staffing ratios. Not the equipment financing commitments across three locations. That one sentence — delivered quietly, almost as an aside — told me everything about what had gone wrong and why it was going to be hard to fix.

She had trained for over a decade to become a medical professional. She was genuinely gifted — her patient retention numbers proved it, her reviews said it, her original clinic had a waitlist. When the second location opened, it made sense. The demand was there. The brand was ready. The decision felt like confidence rewarded.

By the time the third clinic opened, something had shifted — but the momentum made it impossible to pause and name what it was.

When I reviewed the business, the financial picture was complicated. Not catastrophic — complicated. Revenue across three clinics looked healthy in aggregate. But two of the three locations were being quietly carried by the first. The original clinic — her clinic, the one she still saw patients in three days a week — was generating margins that masked the underperformance of the newer outlets.

This is one of the most dangerous positions a multi-outlet healthcare business can be in. Not because the numbers lie. But because they tell a story that feels like success while something underneath is slowly giving way.

The problems came in layers.

The first was inventory — specifically, the consumables and devices used across treatments. Each clinic had developed its own ordering pattern, managed by the clinic coordinator at each location. There was no central oversight, no minimum order discipline, no shared view of what was being used versus what was sitting unused in a storeroom. When we did a full audit, we found over $180,000 in consumables across the three locations — some nearing expiry — that had been ordered based on optimistic treatment volume projections that never materialised.

The second was staffing structure. She had hired generously — understandably so, because quality of care mattered to her deeply and she refused to compromise on it. But the staff-to-patient ratio at the two newer clinics was calibrated for a volume of patients those clinics had not yet reached. Every month, she was paying for capacity that wasn't being used, in locations that hadn't yet earned it.

The third layer was the one she found hardest to hear.

Her pricing had not been reviewed since the second clinic opened. In the intervening period, consumable costs had risen significantly. Device maintenance contracts had increased. Rental at the newer locations was higher than the original. But her treatment prices remained unchanged — because she worried that any increase would feel like a betrayal of the patients who had trusted her.

That instinct was admirable. It was also slowly transferring wealth from her business to her patients in a way that was unsustainable.

We worked through each layer with the care the situation demanded.

On inventory — a centralised ordering system, not sophisticated software, just a shared protocol and a single person accountable for cross-clinic visibility. Consumable spend dropped 31% within two quarters without any reduction in treatment quality.

On staffing — a phased recalibration. Nobody was let go. Instead, we restructured shift patterns at the underperforming clinics to align staffing hours with actual patient flow rather than anticipated flow. This required difficult conversations with staff who had grown accustomed to certain arrangements. She handled every one of those conversations personally, which was the right thing to do and not the easy thing.

On pricing — we built a framework that separated the emotional from the analytical. We benchmarked her prices against the Singapore market for equivalent treatments delivered at equivalent clinical standards. She was, in several categories, priced below mid-market despite delivering outcomes that justified a premium. The adjustment was positioned not as a price increase but as a realignment — and it was communicated to patients with the same care and transparency she brought to everything clinical.

Not a single patient left because of the pricing review.

Twelve months later, all three clinics were cash flow positive for the first time simultaneously. The margin improvement across the group was 19 percentage points. The consumable audit alone recovered enough to fund a new treatment device at the original clinic — one she had been putting off for two years.

And she resumed seeing patients four days a week instead of three.

She told me the thing she hadn't expected was how much lighter the business felt once it was running properly. Not easier — lighter. Like she could breathe inside it again.

She had built something genuinely good. She had just built it faster than the infrastructure could support.

The hardest businesses to sit across from aren't the ones run by people who don't care. They're the ones run by people who care so deeply about their craft that they never learnt to care equally about the business that funds it. One doesn't have to come at the cost of the other. But someone has to be watching both.

The cases in The COO Files reflect real operational patterns and situations encountered across Singapore businesses. Identities, scale, and identifying details have been changed to protect client confidentiality.

Join 1,170+ readers

The COO Files lands every Thursday. Real crises. Real decisions. What actually happened inside Singapore businesses — and what it means for yours.

✓ You're in. See you Thursday.

No spam. No sharing. Unsubscribe anytime.

← Back to all issues